Interim analysis signals efficacy in older patients
Findings may help guide risk-adapted thromboprophylaxis
Findings may help individualize care and optimize patient well-being.
Cleveland Clinic’s pilot study signals efficacy in HHT
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Trial results reported for first molecularly targeted therapy
Please join our staff as we participate or present in the following oral and poster presentations at the 2016 ASH Annual Meeting
Patented CCF642 shows efficacy in mouse myeloma model
Please join our staff as we participate or present in the following oral and poster presentations at the 2016 ASH Annual Meeting
Please join our staff as we participate or present in the following oral and poster presentations at the 2016 ASH Annual Meeting
Learn about featured cancer clinical trials currently enrolling, or search our cancer clinical trials database for all open and accruing studies
Advertisement
Advertisement